3-(methylsulfonyl)-6-oxa-3-azabicyclo[3.1.0]hexane | 185423-66-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 3-(methylsulfonyl)-6-oxa-3-azabicyclo[3.1.0]hexane
• 英文别名: 3-Methanesulfonyl-6-oxa-3-aza-bicyclo[3.1.0]hexane；3-methylsulfonyl-6-oxa-3-azabicyclo[3.1.0]hexane
• CAS: 185423-66-9
• 化学式: C₅H₉NO₃S
• mdl: MFCD11040508
• 分子量: 163.197
• InChiKey: RCADBPVEUXADKB-UHFFFAOYSA-N

物化性质

• 沸点：
  289.1±42.0 °C(Predicted)
• 密度：
  1.50±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -1
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  58.3
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  3-(methylsulfonyl)-6-oxa-3-azabicyclo[3.1.0]hexane 在 palladium on activated charcoal titanium(IV) isopropylate 、 盐酸 、 sodium hydroxide 、 草酰氯 、 氢气 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 生成 4-Benzyloxy-N-((3S,4S)-4-hydroxy-1-methanesulfonyl-pyrrolidin-3-yl)-benzamide
  参考文献：
  名称：

  Synthesis and Protein Kinase C Inhibitory Activities of Balanol Analogs with Replacement of the Perhydroazepine Moiety

  摘要：

  Balanol is a potent protein kinase C (PKC) inhibitor that is structurally composed of a benzophenone diacid, a 4-hydroxybenzamide, and a perhydroazepine ring. A number of balanol analogs in which the perhydroazepine moiety is replaced have been synthesized and their biological activities evaluated against both PKC and cAMP-dependent kinase (PKA). The results suggested that the activity and the isozyme/kinase selectivity of these compounds are largely related to the conformation about this nonaromatic structural element of the molecules.

  DOI：

  10.1021/jm960497g
• 作为产物：
  描述：

  1-甲磺酰基-2,5-二氢吡咯 在 间氯过氧苯甲酸 作用下， 以 二氯甲烷 为溶剂， 生成 3-(methylsulfonyl)-6-oxa-3-azabicyclo[3.1.0]hexane
  参考文献：
  名称：

  Synthesis and Protein Kinase C Inhibitory Activities of Balanol Analogs with Replacement of the Perhydroazepine Moiety

  摘要：

  Balanol is a potent protein kinase C (PKC) inhibitor that is structurally composed of a benzophenone diacid, a 4-hydroxybenzamide, and a perhydroazepine ring. A number of balanol analogs in which the perhydroazepine moiety is replaced have been synthesized and their biological activities evaluated against both PKC and cAMP-dependent kinase (PKA). The results suggested that the activity and the isozyme/kinase selectivity of these compounds are largely related to the conformation about this nonaromatic structural element of the molecules.

  DOI：

  10.1021/jm960497g

文献信息

• Electrolyte Solution for Lithium Secondary Battery and Lithium Secondary Battery Including the Same
  申请人：SK ON CO., LTD.

  公开号：US20240021877A1

  公开（公告）日：2024-01-18

  Provided is an electrolyte solution for a lithium secondary battery and a lithium secondary battery including the electrolyte solution. The electrolyte solution includes an additive represented by a specific chemical formula, an organic solvent and a lithium salt. The lithium secondary battery including the electrolyte solution provide enhanced high-temperature properties.
• Synthesis and Protein Kinase C Inhibitory Activities of Balanol Analogs with Replacement of the Perhydroazepine Moiety
  作者：Yen-Shi Lai、José S. Mendoza、G. Erik Jagdmann、David S. Menaldino、Christopher K. Biggers、Julia M. Heerding、Joseph W. Wilson、Steven E. Hall、Jack B. Jiang、William P. Janzen、Lawrence M. Ballas

  DOI：10.1021/jm960497g

  日期：1997.1.1

  Balanol is a potent protein kinase C (PKC) inhibitor that is structurally composed of a benzophenone diacid, a 4-hydroxybenzamide, and a perhydroazepine ring. A number of balanol analogs in which the perhydroazepine moiety is replaced have been synthesized and their biological activities evaluated against both PKC and cAMP-dependent kinase (PKA). The results suggested that the activity and the isozyme/kinase selectivity of these compounds are largely related to the conformation about this nonaromatic structural element of the molecules.